Quantities of cells used for regenerative medicine and some implications for clinicians and bioprocessors

Regenerative Medicine

Volumn 4, Issue 2, 2009, Pages 153-157

  Mason, Chris ^a   Dunnill, Peter ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLADDER DISEASE; CARTILAGE CELL; CELL COUNT; CELL THERAPY; CEREBROVASCULAR ACCIDENT; HEART FAILURE; HUMAN; KNEE INJURY; LEG ULCER; NONHUMAN; NOTE; PANCREAS ISLET BETA CELL; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPINAL CORD INJURY; CELL TRANSPLANTATION; METHODOLOGY; REGENERATIVE MEDICINE; REVIEW; THERAPY;

CELL COUNT; CELL TRANSPLANTATION; HUMANS; REGENERATIVE MEDICINE; THERAPEUTICS;

EID: 65549135113     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.4.2.153     Document Type: Note

References (15)

1. Mason C, Dunnill P: The crucial linkage required between regenerative medicine bioprocessors and clinicians. Regen. Med. 3, 435-442 (2008).
2. Li Y, Decherchi P, Raisman G: Transplantation of olfactory ensheathing cells in spinal cord lesions restores breathing and climbing. J. Neurosci. 23, 727-731 (2003).
3. Cloutier F, Seigenthaler MM, Nistor G, Keirstead HS: Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. Regen. Med. 1, 469-479 (2006).
4. Passier R, van Laake LW, Mummery CL: Stem-cell-based therapy and lessons from the heart. Nature 453, 322-329 (2008).
5. Burt RK, Lob Y, Pearce W et al.: Clinical applications of blood derived and marrow derived stem cells for non-malignant diseases, JAMA 299, 925-936 (2008).
6. Kroon E, Martinson LA, Kadoya K et al.: Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nature Biotech. 26, 443-452 (2008).
7. Sand T, Condie R, Rosenberg A: Metabolic crowding effect in suspension of cultured lymphocytes. Blood 50, 337-346 (1977).
8. Nassberger L, Truedsson L, Monti M: Microcalorimetric studies of hybridoma cells. Biol. Cell 62, 33-37 (1988).
9. Fontana AJ, Hansen LD, Breidenback RW, Criddle RS: Microcalorimetric measurement of aerobic cell metabolism in unstirred cell culture. Thermochimics Acta 172, 105-113 (1990).
10. De Loecker W, Koptelov VA, Grischenko VI, De Loecker P: Effects of cell concentration on viability and metabolic activity during cryopreservation. Cryobiol. 37, 103-109 (1998).
11. Claxton K, Briggs A, Buxton MJ et al.: Value based pricing for NHS drugs: an opportunity not to be missed? Br. Med. J. 336, 251-254 (2008).
12. Mason C, Dunnill P: The strong ?nancial case for regenerative medicine and the regen industry. Regen. Med. 3, 351-363 (2008).
13. Fernandes AM, Fernandes TG, Diogo MM, da Silva CL, Henrique D, Cabral JM: Mouse embryonic stem cell expansion in a microcarrier-based stirred culture system. J. Biotechnol. 142, 227-236 (2007).
14. Regan DL, Dunnill P, Lilly MD: Immobilized enzyme reaction stability: Attrition of the support material. Biotechnol. Bioeng. 16, 333-343 (1974).
15. Takahashi K, Tanabe K, Ohnuki M et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).